SNGX
Price
$1.36
Change
-$0.01 (-0.73%)
Updated
Jun 27 closing price
Capitalization
4.34M
VRAX
Price
$0.79
Change
+$0.02 (+2.60%)
Updated
Jun 27 closing price
Capitalization
3.39M
Interact to see
Advertisement

SNGX vs VRAX

Header iconSNGX vs VRAX Comparison
Open Charts SNGX vs VRAXBanner chart's image
Soligenix
Price$1.36
Change-$0.01 (-0.73%)
Volume$367.67K
Capitalization4.34M
Virax Biolabs Group
Price$0.79
Change+$0.02 (+2.60%)
Volume$39.15K
Capitalization3.39M
SNGX vs VRAX Comparison Chart in %
Loading...
SNGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SNGX vs. VRAX commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SNGX is a Buy and VRAX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (SNGX: $1.36 vs. VRAX: $0.79)
Brand notoriety: SNGX and VRAX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SNGX: 477% vs. VRAX: 68%
Market capitalization -- SNGX: $4.44M vs. VRAX: $3.39M
SNGX [@Biotechnology] is valued at $4.44M. VRAX’s [@Biotechnology] market capitalization is $3.39M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SNGX’s FA Score shows that 1 FA rating(s) are green whileVRAX’s FA Score has 1 green FA rating(s).

  • SNGX’s FA Score: 1 green, 4 red.
  • VRAX’s FA Score: 1 green, 4 red.
According to our system of comparison, both SNGX and VRAX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SNGX’s TA Score shows that 4 TA indicator(s) are bullish while VRAX’s TA Score has 4 bullish TA indicator(s).

  • SNGX’s TA Score: 4 bullish, 4 bearish.
  • VRAX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both SNGX and VRAX are a good buy in the short-term.

Price Growth

SNGX (@Biotechnology) experienced а -20.00% price change this week, while VRAX (@Biotechnology) price change was -1.13% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SNGX($4.34M) has a higher market cap than VRAX($3.39M). SNGX YTD gains are higher at: -49.536 vs. VRAX (-65.109). VRAX has higher annual earnings (EBITDA): -6.43M vs. SNGX (-10.78M). SNGX (7.3M) and VRAX (7.29M) have equal amount of cash in the bank . SNGX has less debt than VRAX: SNGX (79.1K) vs VRAX (380K). VRAX has higher revenues than SNGX: VRAX (84.9K) vs SNGX (-117.03K).
SNGXVRAXSNGX / VRAX
Capitalization4.34M3.39M128%
EBITDA-10.78M-6.43M168%
Gain YTD-49.536-65.10976%
P/E RatioN/AN/A-
Revenue-117.03K84.9K-138%
Total Cash7.3M7.29M100%
Total Debt79.1K380K21%
FUNDAMENTALS RATINGS
SNGX: Fundamental Ratings
SNGX
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
22
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
94
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
SNGXVRAX
RSI
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 3 days ago
85%
Declines
ODDS (%)
Bearish Trend 10 days ago
90%
Bearish Trend 13 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
85%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
SNGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BAND15.250.81
+5.61%
Bandwidth
Z69.22N/A
N/A
Zillow Group
GRI1.27-0.01
-0.78%
GRI Bio Inc.
THS19.49-0.28
-1.42%
Treehouse Foods
TCRX1.40-0.08
-5.41%
TScan Therapeutics

SNGX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNGX has been closely correlated with ALLR. These tickers have moved in lockstep 85% of the time. This A.I.-generated data suggests there is a high statistical probability that if SNGX jumps, then ALLR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNGX
1D Price
Change %
SNGX100%
-0.73%
ALLR - SNGX
85%
Closely correlated
+2.12%
WINT - SNGX
82%
Closely correlated
+21.49%
RNAC - SNGX
81%
Closely correlated
-6.81%
NRXP - SNGX
81%
Closely correlated
-2.29%
CDTX - SNGX
81%
Closely correlated
+0.24%
More

VRAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VRAX has been loosely correlated with SNGX. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if VRAX jumps, then SNGX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRAX
1D Price
Change %
VRAX100%
+1.95%
SNGX - VRAX
52%
Loosely correlated
-0.73%
ALZN - VRAX
43%
Loosely correlated
-0.68%
GOVX - VRAX
38%
Loosely correlated
+1.04%
BVNKF - VRAX
27%
Poorly correlated
N/A
AURX - VRAX
27%
Poorly correlated
N/A
More